RHABDOMYOSARCOMA APPEAL ICR, Royal Marsden Hospital, London
Registered Charity Number 1085775
TEXT 70070 RHAB18 £5Even £5 will help towards scientific consumables. £25 will help provide cancer research for children and young adults. £50 Will fund 4 hours cancer medical research.
The continuing support of our partners, grant-makers and donors is essential as we seek to fulfill our mission to make the discoveries that defeat Rhabdomyosarcoma cancer.
Statistics show that one in three of us will develop cancer in our lifetime. Even if you are not directly affected, nearly all of us will be moved by the pain and suffering cancer causes to a dear relative or friend.
Our Senior scientist and Assistant are working every day in our lab at the ICR (Institute of Cancer Research in Sutton, Surrey – to make a real impact on childhood cancer patients’ lives. Through our unique partnership the ICR with The Royal Marsden NHS foundation Trust and ‘bench-to-bedside’ approach, we are able to create and deliver results in a way that other institutions cannot. The Chris Lucas Trust are rated the largest organisation to exclusively fund Rhabdomyosarcoma in the whole of Europe.
In partnership with the ICR has an unrivalled track record in cancer research going back over 100 years. Having provided the first convincing evidence that DNA damage is the basic cause of cancer, we laid the foundation for the now universally accepted idea that cancer is a genetic disease. Today the ICR lead the world in isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.
Opportunities for support
As a non-profit organisation, we rely on the generosity of our donors and supporters to:
Developing personalised treatments for cancer is at the very heart of the our partnership with the ICR’s strategy and our scientists and clinicians are at the forefront of research in this field.
Our current funding priorities are:
We are extremely grateful to the many thousands of individuals and organisations who have already helped us in our mission to make the discoveries that defeat Rhabdomyosarcoma cancer.Your support could make all the difference. Thank you.
Buy Now ₤1 GBP or more
We have a great selection of events running, cycling walking, a great way to have fun, getting fit and saving children's lifes
PLEASE SUPPORT CHILDREN'S CANCER MONTH DECEMBER
Chris Lucas Trust's Blog for up to date news
Create and see your Sponsor Form now on-line or donate
See all Chris Lucas Trust Fund-Raisers
theBigGive.org.uk helping your donations go further
Jingle Bell Walk event
The Chris Lucas Trust is established to raise sufficient funds for a Scientific Researcher.
To encourage and support high quality research into Rhabdomyosarcoma, (a very aggressive cancer), with the aim of maintaining and improving human health.
help improve the quality of life of children and young adults.
advance scientific research and disseminate knowledge of research
findings to help other types of cancers with the aim of meeting national
needs in terms of health, quality of life of children and young adults.
promote public engagement with medical research.
work in collaboration with all medical staff to ensure that the Chris
Lucas Trust aims and objectives are adhered to, achieved.
Senior Post Doctoral Scientist
Since September 2005 our appointment of a senior post doctoral scientist to work exclusively on Translational Research in Rhabdomyosarcoma (RMS), he is Italian, based at the ICR, Royal Marsden Hospital, London, Institute of Cancer Research, Innovative Therapies for Children with Cancer (ITCC)
He has very good experience of molecular profiling of cancers and I am sure he will really help us push forward our ongoing work on translational research in rhabdomyosarcoma.
The research group is also very interested in the underlying molecular abnormalities in RMS that might be important as targets for developing new drugs.
Our vital work work on the molecular characterision of rhabdomyosarcoma, using 'microarray' profiling which tests thousands of genes simultaneously.
By looking at how these results predict response to
treatment, we aim to highlight the important genes for
choosing new drugs to test on RMS cell lines and in the
clinic and aim to identify new targets for
developing new drugs.
Chris Lucas Trust says "the costs of doing these types of experiments is expensive, as is the amount needed to keep a scientist working at the bench using modern molecular techniques. We desperately need vital donations to ensure the continuous work of our Senior Researcher".
The funding is over £210,000 for three years (about $368,000) It is so expensive but unfortunately these are the costs of modern molecular medicine".
our Number One Mechanical Backup!
Overseas challenges - Family, Mountain, Trek, Bike, Water, Horse, Community,
Push yourself to new limits, get fit and raise vital funds now for our charity!